|
Androsterone (5α-androstan-3α-ol-17-one)
|
ND; < 4.56
|
ND; < 4.56
|
N/A
|
ND; < 0.63
|
ND; < 0.63
|
N/A
|
|
dehydroepiandrosterone (5-androsten-3β-ol-17-one)
|
36.15 ± 9.74
|
32.91 ± 15.21
|
0.18, P = 0.86
|
0.51 ± 0.02
|
0.53 ± 0.01
|
−1.34, P = 0.23
|
|
Epiandrosterone (5α-androstan-3β-ol-17-one)
|
2.80 ± 0.12
|
3.60 ± 0.44
|
−1.77, P = 0.13
|
0.71 ± 0.02
|
0.72 ± 0.01
|
−0.66, P = 0.54
|
|
Androstenediol (5-androsten-3β,17β-diol)
|
ND; < 0.01
|
ND; < 0.01
|
N/A
|
ND; < 0.45
|
ND; < 0.45
|
N/A
|
|
17β-oestradiol(1,3,5(10)-oestratrien-3,17β-diol)
|
ND; < 0.53
|
ND; < 0.53
|
N/A
|
ND; < 0.05
|
ND; < 0.05
|
N/A
|
|
Testosterone (4-androsten-17β-ol-3-one)
|
19.64 ± 2.27
|
19.63 ± 9.81
|
0.00, P = 1.00
|
ND; < 1.77
|
ND; < 1.77
|
N/A
|
|
Allopregnanolone (5α-pregnan-3α-ol-20-one)
|
1.47 ± 0.27
|
1.95 ± 0.77
|
−0.59, P = 0.58
|
ND; < 0.01
|
ND; < 0.01
|
N/A
|
|
Allopregnanediol (5α-pregnan-3α,20α-diol)
|
ND; < 0.01
|
ND; < 0.01
|
N/A
|
ND; < 0.01
|
ND; < 0.01
|
N/A
|
|
Pregnenolone (5-pregnen-3β-ol-20-one)
|
31.26 ± 13.37
|
25.12 ± 15.05
|
0.31, P = 0.77
|
ND; < 0.01
|
ND; < 0.01
|
N/A
|
|
Epiallopregnanolone (5α-pregnan-3β-ol-20-one)
|
17.07 ± 5.13
|
25.25 ± 17.19
|
−0.46, P = 0.67
|
ND; < 0.37
|
ND; < 0.37
|
N/A
|
|
5α-dihydroprogesterone (5α-pregnan-3,20-dione)
|
12.75 ± 5.26
|
15.01 ± 6.16
|
−0.28, P = 0.79
|
ND; < 0.01
|
ND; < 0.01
|
N/A
|
|
20β-dihydropregnenolone (5-pregnen-3β,20β-diol)
|
ND; < 3.10
|
ND; < 3.10
|
N/A
|
ND; < 0.01
|
ND; < 0.01
|
N/A
|
|
20α-dihydropregnenolone (5-pregnen-3β,20α-diol)
|
0.91 ± 0.11
|
0.94 ± 0.09
|
−0.21, P = 0.84
|
ND; < 0.01
|
ND; < 0.01
|
N/A
|
|
Progesterone (4-pregnen-3,20-dione)
|
3.74 ± 0.34
|
5.84 ± 2.05
|
−1.01, P = 0.35
|
ND; < 4.41
|
ND; < 4.41
|
N/A
|
|
5α,20α-tetrahydroprogesterone (5α-pregnan-20α-ol-3-one)
|
3.71 ± 0.22
|
3.97 ± 0.48
|
−0.50, P = 0.64
|
ND; < 1.61
|
ND; < 1.61
|
N/A
|
